Merck (BSP:MRCK34) Other Current Payables : R$11,960 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Merck Other Current Payables?

Merck's Other Current Payables for the quarter that ended in Mar. 2025 was R$11,960 Mil.

Merck's quarterly Other Current Payables increased from Sep. 2024 (R$10,976 Mil) to Dec. 2024 (R$12,714 Mil) but then declined from Dec. 2024 (R$12,714 Mil) to Mar. 2025 (R$11,960 Mil).

Merck's annual Other Current Payables declined from Dec. 2022 (R$9,882 Mil) to Dec. 2023 (R$9,726 Mil) but then increased from Dec. 2023 (R$9,726 Mil) to Dec. 2024 (R$12,714 Mil).

Merck Other Current Payables Historical Data

The historical data trend for Merck's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Other Current Payables Chart

Merck Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Payables

Get a 7-Day Free Trial

8,612.23

9,997.86

9,882.33

9,726.10

12,714.48

Merck Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Payables	Get a 7-Day Free Trial															9,999.44	10,669.86	10,975.92	12,714.48	11,959.57

Merck Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Merck Other Current Payables Related Terms

Thank you for viewing the detailed overview of Merck's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSP:MRCK34) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRK:Canada 6MK:Bulgaria MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck Headlines

No Headlines